CT/GC Testing to Boost Industry Growth

High incidence rates and availability of technologically-advanced tests will further drive the market for CT/GC testing, says RNCOS.

NOIDA, India (prHWY.com) December 5, 2012 - As per the new research report by RNCOS, "Infectious Disease Molecular Diagnostics Outlook 2015", Chlamydia and Gonorrhea are the two most common bacterial sexually transferred diseases (STDs) in the US. Chlamydia trachomatis (CT) causes the most prevalent bacterial STD infection in the US, with an estimated 2.8 Million new cases every year. Neisseria gonorrhea (GC) is the second most frequently reported bacterial STD in the US and each year, approximately 700,000 people in the country contract gonorrhea.

The market for molecular diagnostics in CT/GC testing reached to the mark of US$ 556 Million in 2011. It is expected to rise backed by factors like rising availability of technologically advanced tests, and cost effectiveness propositions.

The report depicts an effective insight and prudent analysis of the current status and future positioning of the global infectious diseases molecular diagnostics market. It projects the future size of overall market for the period 2012-2015 and covers effective description of key drivers and trends that will propel the growth.

Moreover, the report illustrates the current performance of key infectious disease diagnostic segments (in terms of indications) to enumerate vertical sector demand. It analyzes the opportunity assessment for companies in the market in terms of technologies (e.g. PCR, RT-PCR, NASBA, etc.) and disease prevalence. Additionally, an in-depth insight into the FDA approved diagnostics products along with recent industry developments has been included in the report to provide a balanced outlook on the potentials of the global infectious diseases MDx sector.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM411.htm

Some of our related reports are:

- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
- Brazil Healthcare - New Opportunities for Growth (http://www.rncos.com/Report/IM451.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)
- US Cardiac Device Market Analysis (http://www.rncos.com/Report/IM441.htm)
- US Clinical Laboratory Testing Market Assessment (http://www.rncos.com/Report/IM442.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: molecular diagnostics

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code